Related Experiment Video
Updated: Jun 27, 2026
06:12
Intracerebral Transplantation and In Vivo Bioluminescence Tracking of Human Neural Progenitor Cells in the Mouse Brain
Published on: January 27, 2022
Cell therapy for stroke: remaining issues to address before embarking on clinical trials
1Department of Neurology, Medical College of Georgia, BI-3080, Augusta, GA 30912, USA. cborlongan@mail.mcg.edu
Stroke
|December 10, 2008
Summary
Cell therapy offers a promising approach to extend the stroke treatment window beyond the limitations of current therapies. This strategy targets neurorestoration, potentially improving outcomes for ischemic stroke patients.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Translational Research
Background:
- Stroke is a major cause of disability, with limited treatment options due to narrow therapeutic windows.
- Current treatments like tissue plasminogen activator benefit only a small percentage of ischemic stroke patients.
- Extending the therapeutic window is crucial for improving stroke patient care and management.
Purpose of the Study:
- To evaluate the translational relevance of preclinical stem cell therapy data for clinical application in stroke.
- To explore cell therapy as a method to widen the therapeutic window for stroke treatment.
- To leverage insights from the 2007 Stem Cell Therapeutics as an Emerging Paradigm in Stroke (STEPS) conference.
Main Methods:
- Review of preclinical evidence on stem/progenitor cell transplantation in animal models of stroke.
- Analysis of data for translational relevance to human clinical application.
- Consultation of proceedings from the 2007 STEPS conference.
Main Results:
- Preclinical studies demonstrate that stem/progenitor cell transplantation is safe and effective in animal stroke models.
- Cell therapy targets the neurorestorative phase, which occurs hours to months post-stroke.
- The potential exists to significantly widen the treatment opportunity for stroke patients.
Conclusions:
- Translational research guidelines are being developed by key organizations (academic, industry, NIH, FDA).
- Adherence to these preclinical criteria is essential for clinical translation of cell therapy for stroke.
- Successful advancement of cell therapy from laboratory to clinic relies on rigorous translational research.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...